Skip to content

Clinical trials

Recruiting Observational Pathologic Complete Response trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Phase: Observational Status: Recruiting Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blida 1 University1
Jiangxi Provincial Cancer Hospital1
LMU Klinikum1
MedPacto, Inc.1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1
Sixth Affiliated Hospital, Sun Yat-sen University1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
University Medical Center Groningen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response8
Breast Neoplasms1
Carcinoma, Transitional Cell1
Head and Neck Neoplasms1
Hypersensitivity1
Lung Neoplasms1
Lymphoma, T-Cell, Peripheral1
Nasopharyngeal Carcinoma1
Neoplasm, Residual1
Osteosarcoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.